Article
Increased risk for treatment-related mortality after bone marrow transplantation in GSTM1-positive recipients.
Bone marrow transplantation - 1 Feb 2006
Terakura S, Murata M, Nishida T, Emi N, Akatsuka Y, Morishima Y, Kodera Y, Naoe T
Abstract excerpt
Treatment-related mortality (TRM) is a major obstacle to successful allogeneic hematopoietic stem cell transplantation (HSCT). A variety of drugs are used in allogeneic HSCT, and a genetic polymorphism in metabolic enzymes could affect the metabolism of drugs and potentially influence TRM. Here, we focused attention on GSTM1 and GSTT1 enzymes, which metabolize chemotherapeutic agents, chemical carcinogens and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
